Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events.
Diogo Mendes, Carlos Alves, Francisco Batel Marques
Clin Rheumatol. 2013;32(8):1207-14.
2013
Sources of information used by regulatory agencies on the generation of drug safety alerts.
Carlos Alves, Ana Filipa Macedo, Francisco Batel Marques
Eur J Clin Pharmacol. 2013;69(12):2083-94.
2013
A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer
Carlos Alves, Francisco Batel Marques, Ana Filipa Macedo
Diabetes Res Clin Pract 2012;98(2):271-84
2012
Nurses spontaneous reporting of adverse drug reactions: expert review of routine reports
Diogo Mendes, Carlos Alves, Francisco Batel Marques
Journal of Nursing Management 2012 DOI: 10.1111/jonm.12003
2012
Implemented Data Mining and Signal Management Systems on Spontaneous Reporting Systems Databases and their Availability to the Scientific Community – A Systematic Review
Lima LMAV, Craveiro N, Dias PGP, and Batel Marques FJ
Curr Drug Saf. 2012;7(2):170-5
2012
Iatrogenia grave desconhecida, notificações e notificadores: resultados da actividade da Unidade de Farmacovigilância do Centro
Diogo Mendes, Carlos Alves, Francisco Batel Marques
Rev Port Med Geral Fam 2012;28:34-40
2012
Data sources on drug safety evaluation: a review of recent published meta-analysis
Alves C, Batel Marques F, Craveiro N, Macedo AF
2011
O papel dos farmacêuticos na farmacovigilância
Alves C, Craveiro N, Batel Marques, F
2011
Revisão das fontes de informação utilizadas em meta-análises de segurança
Alves C, Batel Marques F, Craveiro N, Macedo AF
2011
Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions
AF Macedo, C Alves, N Craveiro, F Batel Marques
2011
Safety evaluation of pharmacological interventions: a review of recent published meta-analysis
Alves C, Macedo AF, Craveiro N, Batel Marques F
2011
Increased severity of adverse drug reactions reported from hospitals.
Batel Marques FJ, Alves C, Craveiro N, Fontes-Ribeiro C, Macedo AF
Pharmacoepidemiol Drug Safe 2011;20:S330
2011
Hypersensitivity syndrome due to drug exposure – ten years case review.
Craveiro N, Alves C, Fontes Ribeiro C,Batel Marques FJ
Pharmacoepidemiol Drug Saf 2011;20:S332-S333
2011
Omissão de fármacos modificadores do risco cardiovascular em idosos admitidos numa Unidade de Acidentes Vasculares Cerebrais.
Borges EP, Macedo AF
Rev Port Clin Geral 2011;27:140-150
2011
Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.
Alves C, Macedo AF, Batel Marques F
Pharmacotherapy 2011;31(10):357e
2011
Fecundação in vitro em Portugal: um estudo de custo-efectividade.
Silva V, Pita Barros P, Lourenço O, Batel-Marques F.
Rev Port Farmacoter 2011;3:139-153
2011
Data sources on drug safety evaluation: a review of recent published meta-analysis.
Alves C, Batel Marques F, Macedo AF
Pharmacoepidemiol Drug Saf 2012;21(1):21-33
2011
Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.
Alves C, Batel-Marques F, Macedo AF.
J Cardiovasc Pharmacol Therap 2011 1 Dec. doi: 10.1177/1074248411427402
2011